Quercus Molecular Design, a UConn spinout, has won Phase I STTR funding from the National Institutes of Health to develop treatments for Herpes Simplex Virus.

The one-year grant focuses on the development of multi-targeting inhibitors that block two or more essential proteins used in reproduction of the virus.

more